Cornea/External Disease News

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, John P. Berdahl, MD, discusses cell therapy for corneal conditions.

DENVER — The incidence of methicillin-resistant Staphylococcus aureus has gone down slightly but is still significant at 37%, Penny A. Asbell, MD, MBA, FARVO, said at the ARVO meeting.

DENVER — Corneal stress distribution is driven by thickness in normal eyes but is influenced more by curvature in eyes with keratoconus, according to a presenter here.

A 67-year-old man was referred to the cornea clinic with complaints of progressive vision decline, mild pain and tearing of the right eye.

Ocular conditions in women depend on several factors, including genes, hormones, comorbidities, physiological changes, stress levels and lifestyles.

DENVER — Anterior chamber volume and depth are significantly lower in individuals who are Hispanic white as compared with non-Hispanic white, according to a presenter here.

DENVER — A large phase 2b study showed that the use of Aerie Pharmaceuticals’ AR-15512 compound resulted in improved tear production and dry eye symptoms at 7 days and 14 days, according to David Wirta, MD, of the Eye Research Foundation.

In this Healio Video Perspective, Bobak Azamian, MD, PhD, CEO and co-founder of Tarsus Pharmaceuticals, discusses topline data from the Saturn-2 phase 3 study of TP-03 for the treatment of Demodex blepharitis.

WASHINGTON — Patients who underwent Dextenza implantation had improvements in itching due to allergic conjunctivitis through 30 days, according to a study.

WASHINGTON — A phase 2 study found that ST-100, a collagen mimetic peptide, could provide a new avenue for treatment of dry eye disease, according to a presenter at the American Society of Cataract and Refractive Surgery meeting.